Format

Send to

Choose Destination
See comment in PubMed Commons below
Pharmacogenomics. 2008 Sep;9(9):1211-5. doi: 10.2217/14622416.9.9.1211.

Sequenom, Inc.

Author information

1
Sequenom, Inc., 3595 John Hopkins Ct., San Diego, CA 92121, USA.

Abstract

Sequenom is an established genomic analysis company with two principal divisions: genetic analysis systems and reagents, and noninvasive prenatal diagnostics. As an industry innovator in DNA detection technology, Sequenom's benchtop MassARRAY Compact system allows a direct mass measurement of nucleic acids, providing unparalleled precision and quantitation. The MassARRAY system is a multi-application MALDI-TOF MS platform for genotyping, methylation and quantitative gene expression analysis. Sequenom continues to refine these core applications and has developed several new applications for copy number variation analysis and comparative sequence analysis for bacteria and viruses. On the diagnostics front, Sequenom is developing a comprehensive portfolio of prenatal test methods by combining the versatility of the MassARRAY system with the Company's SEQureDxtrade mark technology, which enables the detection of circulating cell-free fetal nucleic acids in a maternal blood sample.

PMID:
18781849
DOI:
10.2217/14622416.9.9.1211
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center